Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11641259rdf:typepubmed:Citationlld:pubmed
pubmed-article:11641259lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:11641259lifeskim:mentionsumls-concept:C0020517lld:lifeskim
pubmed-article:11641259lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:11641259lifeskim:mentionsumls-concept:C0020846lld:lifeskim
pubmed-article:11641259lifeskim:mentionsumls-concept:C0162768lld:lifeskim
pubmed-article:11641259pubmed:issue13lld:pubmed
pubmed-article:11641259pubmed:dateCreated2001-11-5lld:pubmed
pubmed-article:11641259pubmed:abstractTextBy screening phage display random peptide libraries with purified immunoglobulin E (IgE) from birch pollen-allergic patients, we previously defined peptides mimicking natural IgE epitopes (mimotopes) of the major birch pollen allergen Bet v 1. The present study aimed to define a monovalent carrier for the IgE mimotopes to induce protective antibodies directed to the IgE epitopes, suitable for mimotope-specific therapy. We expressed the selected mimotopes as fusion proteins together with streptococcal albumin binding protein (ABP). The fusion proteins were recognized specifically by anti-Bet v 1 human IgE, which demonstrated that the mimotopes fused to ABP resemble the natural IgE epitope. Bet v 1-specific IgG was induced by immunization of BALB/c mice with fusion proteins. These IgG antibodies could inhibit IgE binding to Bet v 1. Skin testing of Bet v 1 allergic mice showed that the ABP mimotope constructs did not elicit type I skin reactions, although they possess IgE binding structures. Our data suggest that IgE mimotopes are safe for epitope-specific immunotherapy of sensitized individuals, when presented in a monovalent form. Therefore, ABP-fused mimotopes are promising candidates for a new type of immunotherapy based on the precise induction of blocking antibodies.lld:pubmed
pubmed-article:11641259pubmed:languageenglld:pubmed
pubmed-article:11641259pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11641259pubmed:citationSubsetIMlld:pubmed
pubmed-article:11641259pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11641259pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11641259pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11641259pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11641259pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11641259pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11641259pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11641259pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11641259pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11641259pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11641259pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11641259pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11641259pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11641259pubmed:statusMEDLINElld:pubmed
pubmed-article:11641259pubmed:monthNovlld:pubmed
pubmed-article:11641259pubmed:issn1530-6860lld:pubmed
pubmed-article:11641259pubmed:authorpubmed-author:ScheinerOOlld:pubmed
pubmed-article:11641259pubmed:authorpubmed-author:Boltz-Nitules...lld:pubmed
pubmed-article:11641259pubmed:authorpubmed-author:SuterMMlld:pubmed
pubmed-article:11641259pubmed:authorpubmed-author:SchöllIIlld:pubmed
pubmed-article:11641259pubmed:authorpubmed-author:BreitenederHHlld:pubmed
pubmed-article:11641259pubmed:authorpubmed-author:BaumannSSlld:pubmed
pubmed-article:11641259pubmed:authorpubmed-author:Jensen-Jaroli...lld:pubmed
pubmed-article:11641259pubmed:authorpubmed-author:WiedermannUUlld:pubmed
pubmed-article:11641259pubmed:authorpubmed-author:HafnerCClld:pubmed
pubmed-article:11641259pubmed:authorpubmed-author:GanglbergerEElld:pubmed
pubmed-article:11641259pubmed:authorpubmed-author:Barbara...lld:pubmed
pubmed-article:11641259pubmed:issnTypeElectroniclld:pubmed
pubmed-article:11641259pubmed:volume15lld:pubmed
pubmed-article:11641259pubmed:ownerNLMlld:pubmed
pubmed-article:11641259pubmed:authorsCompleteYlld:pubmed
pubmed-article:11641259pubmed:pagination2524-6lld:pubmed
pubmed-article:11641259pubmed:dateRevised2011-6-21lld:pubmed
pubmed-article:11641259pubmed:meshHeadingpubmed-meshheading:11641259...lld:pubmed
pubmed-article:11641259pubmed:meshHeadingpubmed-meshheading:11641259...lld:pubmed
pubmed-article:11641259pubmed:meshHeadingpubmed-meshheading:11641259...lld:pubmed
pubmed-article:11641259pubmed:meshHeadingpubmed-meshheading:11641259...lld:pubmed
pubmed-article:11641259pubmed:meshHeadingpubmed-meshheading:11641259...lld:pubmed
pubmed-article:11641259pubmed:meshHeadingpubmed-meshheading:11641259...lld:pubmed
pubmed-article:11641259pubmed:meshHeadingpubmed-meshheading:11641259...lld:pubmed
pubmed-article:11641259pubmed:meshHeadingpubmed-meshheading:11641259...lld:pubmed
pubmed-article:11641259pubmed:meshHeadingpubmed-meshheading:11641259...lld:pubmed
pubmed-article:11641259pubmed:meshHeadingpubmed-meshheading:11641259...lld:pubmed
pubmed-article:11641259pubmed:meshHeadingpubmed-meshheading:11641259...lld:pubmed
pubmed-article:11641259pubmed:meshHeadingpubmed-meshheading:11641259...lld:pubmed
pubmed-article:11641259pubmed:meshHeadingpubmed-meshheading:11641259...lld:pubmed
pubmed-article:11641259pubmed:meshHeadingpubmed-meshheading:11641259...lld:pubmed
pubmed-article:11641259pubmed:meshHeadingpubmed-meshheading:11641259...lld:pubmed
pubmed-article:11641259pubmed:meshHeadingpubmed-meshheading:11641259...lld:pubmed
pubmed-article:11641259pubmed:meshHeadingpubmed-meshheading:11641259...lld:pubmed
pubmed-article:11641259pubmed:meshHeadingpubmed-meshheading:11641259...lld:pubmed
pubmed-article:11641259pubmed:meshHeadingpubmed-meshheading:11641259...lld:pubmed
pubmed-article:11641259pubmed:meshHeadingpubmed-meshheading:11641259...lld:pubmed
pubmed-article:11641259pubmed:meshHeadingpubmed-meshheading:11641259...lld:pubmed
pubmed-article:11641259pubmed:meshHeadingpubmed-meshheading:11641259...lld:pubmed
pubmed-article:11641259pubmed:meshHeadingpubmed-meshheading:11641259...lld:pubmed
pubmed-article:11641259pubmed:year2001lld:pubmed
pubmed-article:11641259pubmed:articleTitleMonovalent fusion proteins of IgE mimotopes are safe for therapy of type I allergy.lld:pubmed
pubmed-article:11641259pubmed:affiliationDepartment of Pathophysiology, University of Vienna, A-1090 Vienna, Austria.lld:pubmed
pubmed-article:11641259pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11641259lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11641259lld:pubmed